Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 1, 2001, Pages 185-194

  Pilette, C ^a   Godding, V ^a   Kiss, R ^a   Delos, M ^a   Verbeken, E ^a   Decaestecker, C ^a   De Paepe, K ^a   Vaerman, J P ^a   Decramer, M ^a   Sibille, Y ^a  

^a Unité Medecine experimentale   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLARA CELL PROTEIN; SECRETORY COMPONENT;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHIOLE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOHISTOCHEMISTRY; LUNG ENDOTHELIUM; LUNG FLOW VOLUME CURVE; LUNG FUNCTION; LUNG TRANSPLANTATION; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SMOKING; SUBMUCOSA;

EID: 0035152929     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.1.9912137     Document Type: Article

References (35)

1. Immune functions and immunopathology of the mucosa of the upper respiratory pathways
2. Immunoglobulin A: Strategic defence at the mucosal surface
3. Cells of the lung: Biology and clinical implications
4. Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein
5. Clara cell protein in serum and bronchoalveolar lavage of healthy subjects and patients with pulmonary diseases
6. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
7. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease
8. Site and nature of airway obstruction in chronic obstructive lung disease
9. Consensus statement optimal assesment and management of chronic obstructive pulmonary disease (COPD)
10. Severity of airflow limitation is associated with severity of airflow inflammation in smokers
11. IgA subclasses in various secretions and in serum
12. International guidelines for the selection of lung transplant candidates
13. Assessment of lung parenchymal destruction by using routine histologic tissue sections
14. A solid phase, direct competition, radioimmunoassay for quantification of secretory IgA in human serum
15. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins
16. Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: Relationship to lung function
17. Ultrastructural evidence of transport of secretory IgA across bronchial epithelium
18. Goblet and Clara cells of human distal airways: Evidence for smoking induced changes in their numbers
19. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CCl0-positive bronchiolar cells are decreased in smokers
20. Number and proliferation of Clara cells in normal human airway epithelium
21. Free secretory component and other proteins in human lung lavage
22. Alpha-2-macroglobulin, monomeric and polymeric immunoglobulin A, and immunoglobulion M in bronchoalveolar lavage
23. Assessment of 7S and 11S immunoglobulin A in sputum
24. IgA subclasses in sputum from patients with bronchiectasis
25. Lactoferrin and secretory IgA in the bronchoalveolar lavage fluid from patients with a stable asthma
26. Inhibition of receptor-dependent and receptor-independent generation of the repiratory burst in human neutrophils and monocytes by human serum IgA
27. Endotoxin stimulates bronchial epithelial cells to release chemotactic factors for neutrophils
28. Influence of sputum IgA and elastase on tracheal cell bacterial adherence
29. Morphologic and morphometric effects of prolonged cigarette smoking on the small airways
30. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry
31. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis
32. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis
33. Effect of high dose inhaled steroids on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease
34. The relationship between structural changes in small airways and pulmonary-function tests
35. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice